| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Cyteir Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 14,150 | 22 Feb 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000089924322007641-naesens-janwillem-2022-02-22 | Cyteir Therapeutics, Inc. | 22 Feb 2022 | 1 | $0 | 4 | Director | 24 Feb 2022, 15:57 |
| /report/000089924321025824-naesens-janwillem-2021-06-22 | Cyteir Therapeutics, Inc. | 22 Jun 2021 | 4 | +$4,999,986 | 4 | Director | 24 Jun 2021, 20:50 |
| /report/000089924321024594-naesens-janwillem-2021-06-17 | Cyteir Therapeutics, Inc. | 17 Jun 2021 | 0 | $0 | 3 | Director | 17 Jun 2021, 21:40 |